- Radnor’s CaBaletta, Philly’s latest Biotech star, files for $100 million IPO. CaBaletta is a clinical-stage developer of treatments for autoimmune diseases.
- From Philly JoeD: Dogfight over: Petplan sold to a new private equity owner; dueling owners exit dueling owners settle and exit
- Boomi kicks off Fall Show with new branding
- Boomi Partners with Accenture to Introduce Conversational AI Solutions
- Does the latest Boomi news position it as Dell’s next rising star?
- Health care startup TrekIT gets new CEO, funding #McCorkle moves on .